journal article·2024-06Open access

Molecular mechanism of protein aggregation inhibition with sulfobetaine polymers and their hydrophobic derivatives

Robin Rajan, Tadaomi Furuta, Dandan Zhao, Kazuaki Matsumura

Cell Reports Physical Science· Volume 5· Issue 6

Abstract

Protein aggregation is a major biomedical challenge necessitating effective protein stabilization strategies. However, the specific interactions between hydrophobic components and proteins in relation to protein aggregation remain poorly understood. Here, we investigate the molecular mechanism of protein aggregation inhibition using zwitterionic polymers, revealing their remarkable efficiency in suppressing protein aggregation. Higher molecular weight and increased hydrophobic modification greatly contribute to near-complete inhibition. Comprehensive investigations employing various techniques unravel weak and reversible interactions between sulfobetaine polymers and proteins, amplified by increasing hydrophobicity and molecular weight. The polymers serve as reversible molecular shields, disrupting the aggregation pathway and impeding the formation of highly aggregation-prone intermediates. Upon stress removal, partially unfolded intermediates regain their native states through refolding. This study represents a comprehensive exploration of protein stabilization with zwitterionic polymers, yielding valuable insights into protein denaturation, the aggregation pathway, and protein-folding dynamics. These findings hold potential for advancing protein therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protein purification and stability · Protein Structure and Dynamics · Enzyme Structure and Function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Protein aggregation and neurodegenerative disease10.1038/nm1066 ↗
2. Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials10.1039/D0MA00760A ↗
3. Protein aggregation and its inhibition in biopharmaceutics10.1016/j.ijpharm.2004.11.014 ↗
4. Therapeutic protein aggregation: mechanisms, design, and control10.1016/j.tibtech.2014.05.005 ↗
5. Challenges and solutions for the downstream purification of therapeutic proteins
6. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges10.4331/wjbc.v3.i4.73 ↗
7. Prevention of thermal inactivation and aggregation of lysozyme by polyamines10.1046/j.1432-1033.2003.03850.x ↗
8. Role of Arginine in Protein Refolding, Solubilization, and Purification10.1021/bp0498793 ↗
9. Vitamin E Prevents Alzheimer’s Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production10.3233/JAD-2000-2212 ↗
10. Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases10.1038/srep26759 ↗
11. Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases10.1016/j.nbd.2006.10.010 ↗
12. Inhibition of protein misfolding and aggregation by natural phenolic compounds10.1007/s00018-018-2872-2 ↗
13. Inhibition of Protein Misfolding and Aggregation by Small Rationally-Designed Peptides10.2174/138161206777698792 ↗
14. Effect of NDSB on the Protein Aggregation10.14723/tmrsj.33.479 ↗
15. Non-detergent sulphobetaines: a new class of molecules that facilitate in vitro protein renaturation10.1016/S1359-0278(96)00008-9 ↗
16. Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification10.1042/bj3050337 ↗
17. A Structured Monodisperse PEG for the Effective Suppression of Protein Aggregation10.1002/anie.201206563 ↗
18. Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage10.1039/C8MH00727F ↗
19. Poly(trehalose) Nanoparticles Prevent Amyloid Aggregation and Suppress Polyglutamine Aggregation in a Huntington’s Disease Model Mouse10.1021/acsami.7b06510 ↗
20. Trehalose Glycopolymers for Stabilization of Protein Conjugates to Environmental Stressors10.1021/ja2120234 ↗
21. A zwitterionic polymer as a novel inhibitor of protein aggregation10.1039/C5TB01021G ↗
22. Design of self-assembled glycopolymeric zwitterionic micelles as removable protein stabilizing agents10.1039/D3NA00002H ↗
23. Polyethylene-glycol-modified zwitterionic polymer assisted protein aggregation arrest and refolding10.1039/D2ME00084A ↗
24. Dual Thermo- and pH-Responsive Behavior of Double Zwitterionic Graft Copolymers for Suppression of Protein Aggregation and Protein Release10.1021/acsami.9b12723 ↗
25. Comparative Study of Protein Aggregation Arrest by Zwitterionic Polysulfobetaines: Using Contrasting Raft Agents10.1021/acsomega.9b01409 ↗
26. Facile Photolithographic Fabrication of Zwitterionic Polymer Microneedles with Protein Aggregation Inhibition for Transdermal Drug Delivery10.1021/acs.biomac.1c01325 ↗
27. Inhibition of protein aggregation by zwitterionic polymer-based core-shell nanogels10.1038/srep45777 ↗
28. Targeting protein aggregation for the treatment of degenerative diseases10.1038/nrd4593 ↗
29. Identification of pathogenic missense mutations using protein stability predictors10.1038/s41598-020-72404-w ↗
30. Effects of several quinones on insulin aggregation10.1038/srep05648 ↗
31. Inhibition of insulin fibrillation by osmolytes: Mechanistic Insights10.1038/srep17599 ↗
32. The formation of spherulites by amyloid fibrils of bovine insulin10.1073/pnas.0405933101 ↗
33. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data10.1093/nar/gkh371 ↗
34. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set10.1006/abio.2000.4880 ↗
35. 1-anilinonaphthalene-8-sulfonate (ANS); a versatile fluorescent probe from protein folding study to drug design
36. Biomimetic materials based on zwitterionic polymers toward human-friendly medical devices10.1080/14686996.2022.2119883 ↗
37. Surface plasmon resonance spectroscopy for characterisation of membrane protein–ligand interactions and its potential for drug discovery10.1016/j.bbamem.2013.04.028 ↗
38. Potential Use of Maltosyl-β-cyclodextrin for Inhibition of Insulin Self-association in Aqueous Solution
39. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution10.1248/cpb.45.525 ↗
40. Studies In The Physical Chemistry Of The Proteins: VIII. The Solubility Of Hemoglobin In Concentrated Salt Solutions. A Study Of The Salting Out Of Proteins10.1016/S0021-9258(18)76456-9 ↗
41. Molecular dynamics and protein function10.1073/pnas.0408930102 ↗
42. A spectroscopic investigation into the interaction between bile salts and insulin in alkaline aqueous solution10.1016/j.jcis.2009.05.056 ↗
43. Tyrosyl fluorescence in proteins and model peptides
44. Permyakov · 1993
45. Zwitterionic Polymer Design that Inhibits Aggregation and Facilitates Insulin Refolding: Mechanistic Insights and Importance of Hydrophobicity10.1002/mabi.201800016 ↗
46. Tyrosine autofluorescence as a measure of bovine insulin fibrillation10.1016/j.bpj.2009.07.064 ↗
47. Tryptophan fluorescence of serum albumins
48. Use of the Phase Diagram Method to Analyze the Protein Unfolding-Refolding Reactions: Fishing Out the “Invisible” Intermediates10.1021/pr034094y ↗
49. Thermal dissociation and unfolding of insulin10.1021/bi0507940 ↗
50. Both plant and animal LEA proteins act as kinetic stabilisers of polyglutamine-dependent protein aggregation10.1016/j.febslet.2011.01.020 ↗
51. Intrinsically disordered proteins as molecular shields10.1039/C1MB05263B ↗
52. Case · 2016
53. The structure of T6 bovine insulin10.1107/S0907444905025771 ↗